Union Talniphrumate Tablets

Adult dose

Administer 370 mg of talniflumate orally 3 times daily. For severe cases, administer 740 mg per dose. Adjust the dose as appropriate according to age and symptoms.

This medication should be consulted with a doctor or pharmacist before taking by individuals who regularly consume more than three alcoholic beverages daily. There is a risk of gastrointestinal bleeding if this medication is taken with this or other antipyretic analgesics. This medication can affect the cardiovascular system and may increase the risk of serious thrombotic reactions such as heart attack or stroke. Patients with cardiovascular diseases or risk factors should be particularly careful, and both the doctor and patient should closely monitor for cardiovascular symptoms. This medication can also affect the gastrointestinal system, posing risks for serious adverse reactions such as bleeding, ulcers, or perforations in the stomach or intestines. These symptoms can appear suddenly and without warning, especially in the elderly. Patients with a history of peptic ulcers or allergic reactions to this drug or its components should not take this medication. Also, individuals with asthma, hives, or a history of aspirin allergy should not take it, and pregnant or nursing women should avoid this medication. Patients with compromised liver or kidney function, older adults, and those allergic to certain pigment components should use this medication cautiously. Various side effects such as nausea, vomiting, diarrhea, abdominal pain, skin rash, dizziness may occur while taking this medication, and immediate consultation with healthcare personnel is necessary if any unusual symptoms develop. It is advisable to avoid taking this medication with other anti-inflammatory analgesics, and it may interact with blood pressure medications, diuretics, anticoagulants, lithium, methotrexate, so it is essential to inform the healthcare provider of any other medications being taken. During pregnancy, particularly in later stages, it may pose risks to the fetus, so women of childbearing potential should avoid using it, and nursing mothers should either discontinue breastfeeding or consult a doctor while taking this medication. This medication should not be used in children, particularly those under 12, and elderly patients should use the minimal effective dosage with caution. This medication should be stored out of reach of children, and it is important to avoid transferring it to other containers, as this can compromise its quality.

• Gastrointestinal bleeding
• cardiovascular thrombotic reactions
• myocardial infarction
• stroke
• nausea
• vomiting
• photosensitivity
• asthma attack
• systemic lethargy due to hypotension
• hypersensitivity shock

This medication should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be kept between 1°C to 30°C. Storing it this way will help maintain the medication's effectiveness.

Appearance

Round yellow film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle